Biotech Growth (UK) Alpha and Beta Analysis
| BIOG Stock | 867.00 7.00 0.81% |
This module allows you to check different measures of market premium (i.e., alpha and beta) for all equities such as The Biotech Growth. It also helps investors analyze the systematic and unsystematic risks associated with investing in Biotech Growth over a specified time horizon. Remember, high Biotech Growth's alpha is almost always a sign of good performance; however, a high beta will depend on investors' risk tolerance level and may signal increased volatility and potential future overvaluation. Key technical indicators related to Biotech Growth's market risk premium analysis include:
Beta 0.55 | Alpha (0.31) | Risk 1.53 | Sharpe Ratio (0.16) | Expected Return (0.25) |
Alpha is a measure of relative performance on a risk-adjusted basis, while beta measures volatility against the benchmark. The goal is to know if an investor is being compensated for the volatility risk taken. The return on investment might be better than its reference but still not compensate for the assumption of the risk.
Biotech |
Biotech Growth Market Premiums
Investors always prefer to have the highest possible return on investment, coupled with the lowest possible volatility. Biotech Growth market risk premium is the additional return an investor will receive from holding Biotech Growth long position in a well-diversified portfolio. The market premium is part of the Capital Asset Pricing Model (CAPM), which most analysts and investors use to calculate the acceptable rate of return on investment in Biotech Growth. At the center of the CAPM is the concept of risk and reward, which is usually communicated by investors using alpha and beta measures. Alpha and beta are two of the key measurements used to evaluate Biotech Growth's performance over market.| α | -0.31 | β | 0.55 |
Biotech Growth expected buy-and-hold returns
Although buy-and-hold investment strategy may not appeal to all investors, it may be used as a good measure of Biotech Growth's Buy-and-hold return. Our buy-and-hold chart shows how Biotech Growth performed over your current time horizon against a typical interest-earning bank account and a selected benchmark.Biotech Growth Market Price Analysis
Market price analysis indicators help investors to evaluate how Biotech Growth stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Biotech Growth shares will generate the highest return on investment. By understating and applying Biotech Growth stock market price indicators, traders can identify Biotech Growth position entry and exit signals to maximize returns.
Biotech Growth Return and Market Media
The median price of Biotech Growth for the period between Tue, Oct 29, 2024 and Mon, Jan 27, 2025 is 913.0 with a coefficient of variation of 7.43. The daily time series for the period is distributed with a sample standard deviation of 68.78, arithmetic mean of 925.33, and mean deviation of 60.38. The Stock received some media coverage during the period. Price Growth (%) |
| Timeline |
1 | Nicola Shepherd Acquires 1,000 Shares of The Biotech Growth Trust PLC Stock - MarketBeat | 01/13/2025 |
About Biotech Growth Beta and Alpha
For many years both, Alpha and Beta indicators are used by professional money managers as critical performance measurement tools across virtually all financial instruments including Biotech or other stocks. Alpha measures the amount that position in Biotech Growth has returned in comparison to a selected market index or another relevant benchmark. In other words, Alpha is the excess return on an investment relative to the performance of your selected benchmark. Beta, on the other hand, measures the relative risk of your investment.
Some investors attempt to determine whether the market's mood is bullish or bearish by monitoring changes in market sentiment. Unlike more traditional methods such as technical analysis, investor sentiment usually refers to the aggregate attitude towards Biotech Growth in the overall investment community. So, suppose investors can accurately measure the market's sentiment. In that case, they can use it for their benefit. For example, some tools to gauge market sentiment could be utilized using contrarian indexes, Biotech Growth's short interest history, or implied volatility extrapolated from Biotech Growth options trading.
Build Portfolio with Biotech Growth
Your optimized portfolios are the building block of your wealth. We provide an intuitive interface to determine which securities in a portfolio should be removed or rebalanced to achieve better diversification, find the right mix of securities that minimizes portfolio risk for a given return, or maximize portfolio expected return for a given risk level.Build Diversified Portfolios
Align your risk with return expectations
Additional Tools for Biotech Stock Analysis
When running Biotech Growth's price analysis, check to measure Biotech Growth's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Biotech Growth is operating at the current time. Most of Biotech Growth's value examination focuses on studying past and present price action to predict the probability of Biotech Growth's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Biotech Growth's price. Additionally, you may evaluate how the addition of Biotech Growth to your portfolios can decrease your overall portfolio volatility.